Univariate analysis of the risk of reassessment and re-investigation by neurological diagnosis
| Relative risk (95% CI) and p value | ||||
| Reassessment | Re-investigation | |||
| Negative likelihood | ||||
| Headaches and facial pains | 0.22 (0.11 to 0.43) | <0.001 | 0.13 (0.04 to 0.41) | <0.001 |
| Epileptic seizures | 0.37 (0.12 to 1.12) | 0.052 | 0.22 (0.03 to 1.57) | 0.086 |
| Positive likelihood | ||||
| Multiple sclerosis and neuroinflammatory disorders | 2.18 (1.24 to 3.85) | 0.013 | 3.82 (2.00 to 7.32) | <0.001 |
| Spinal disorders and radiculopathies | 2.28 (1.36 to 3.84) | 0.004 | 1.14 (0.38 to 3.47) | 0.810 |
| Non-specific neurological symptoms | 1.75 (1.04 to 2.96) | 0.045 | 1.99 (0.95 to 4.16) | 0.071 |
| Functional neurological disorders | 1.41 (0.90 to 2.21) | 0.145 | 1.37 (0.71 to 2.63) | 0.353 |
| Neuromuscular and cranial neuropathies | 1.45 (0.83 to 2.52) | 0.208 | 1.81 (0.86 to 3.79) | 0.123 |
| Vestibular and cerebellar disorder | 1.58 (0.66 to 3.76) | 0.327 | 0.71 (0.10 to 4.79) | 0.716 |
| Movement disorders | 1.27 (0.68 to 2.35) | 0.461 | 1.04 (0.39 to 2.75) | 0.941 |